{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T22:00:42Z","timestamp":1790892042869,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14669"],"award-info":[{"award-number":["23K14669"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11060-025-05035-8","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T12:54:31Z","timestamp":1744203271000},"page":"85-95","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Repeat stereotactic radiosurgery for recurrent brain metastases: a retrospective comparison of local progression and distant brain metastases after prior radiosurgery"],"prefix":"10.1007","volume":"174","author":[{"given":"Masamune","family":"Noguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaro","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurika","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tachibana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kodaira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinji","family":"Naganawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"5035_CR1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noae220","author":"R Kotecha","year":"2024","unstructured":"Kotecha R, La Rosa A, Brown PD et al (2024) Multidisciplinary management strategies for recurrent brain metastasis after prior radiotherapy: an overview. Neuro Oncol. https:\/\/doi.org\/10.1093\/neuonc\/noae220","journal-title":"Neuro Oncol"},{"key":"5035_CR2","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40:492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"key":"5035_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.prro.2022.02.003","volume":"12","author":"V Gondi","year":"2022","unstructured":"Gondi V, Bauman G, Bradfield L et al (2022) Radiation therapy for brain metastases: an ASTRO clinical practice guideline. Pract Radiat Oncol 12:265\u2013282. https:\/\/doi.org\/10.1016\/j.prro.2022.02.003","journal-title":"Pract Radiat Oncol"},{"key":"5035_CR4","doi-asserted-by":"publisher","first-page":"101402","DOI":"10.1016\/j.adro.2023.101402","volume":"9","author":"C Ladbury","year":"2024","unstructured":"Ladbury C, Pennock M, Yilmaz T et al (2024) Stereotactic radiosurgery in the management of brain metastases: A Case-Based radiosurgery society practice guideline. Adv Radiat Oncol 9:101402. https:\/\/doi.org\/10.1016\/j.adro.2023.101402","journal-title":"Adv Radiat Oncol"},{"key":"5035_CR5","doi-asserted-by":"publisher","first-page":"102233","DOI":"10.1016\/j.esmoop.2024.102233","volume":"9","author":"I Michelon","year":"2024","unstructured":"Michelon I, Vilbert M, Marinho AD et al (2024) Trastuzumab Deruxtecan in human epidermal growth factor receptor 2-positive breast cancer brain metastases: a systematic review and meta-analysis. ESMO Open 9:102233. https:\/\/doi.org\/10.1016\/j.esmoop.2024.102233","journal-title":"ESMO Open"},{"key":"5035_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/jamaoncol.2022.5610","volume":"9","author":"NU Lin","year":"2023","unstructured":"Lin NU, Murthy RK, Abramson V et al (2023) Tucatinib vs placebo, both in combination with trastuzumab and capecitabine, for previously treated ERBB2 (HER2)-Positive metastatic breast cancer in patients with brain metastases: updated exploratory analysis of the HER2CLIMB randomized clinical trial. JAMA Oncol 9:197\u2013205. https:\/\/doi.org\/10.1001\/jamaoncol.2022.5610","journal-title":"JAMA Oncol"},{"key":"5035_CR7","doi-asserted-by":"publisher","unstructured":"Tonse R, Tom MC, Mehta MP et al (2021) Integration of systemic therapy and stereotactic radiosurgery for brain metastases. Cancers 13. https:\/\/doi.org\/10.3390\/cancers13153682","DOI":"10.3390\/cancers13153682"},{"key":"5035_CR8","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1200\/JCO.20.01255","volume":"38","author":"PW Sperduto","year":"2020","unstructured":"Sperduto PW, Mesko S, Li J et al (2020) Survival in patients with brain metastases: summary report on the updated Diagnosis-Specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773\u20133784. https:\/\/doi.org\/10.1200\/JCO.20.01255","journal-title":"J Clin Oncol"},{"key":"5035_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11060-022-04132-2","volume":"160","author":"Y Koide","year":"2022","unstructured":"Koide Y, Nagai N, Miyauchi R et al (2022) Radiotherapy or systemic therapy versus combined therapy in patients with brain metastases: a propensity-score matched study. J Neurooncol 160:191\u2013200. https:\/\/doi.org\/10.1007\/s11060-022-04132-2","journal-title":"J Neurooncol"},{"key":"5035_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1200\/JCO.19.02767","volume":"38","author":"PD Brown","year":"2020","unstructured":"Brown PD, Gondi V, Pugh S et al (2020) Hippocampal avoidance during Whole-Brain radiotherapy plus memantine for patients with brain metastases: phase III trial NRG oncology CC001. J Clin Oncol 38:1019\u20131029. https:\/\/doi.org\/10.1200\/JCO.19.02767","journal-title":"J Clin Oncol"},{"key":"5035_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.ijrobp.2023.04.030","volume":"117","author":"V Gondi","year":"2023","unstructured":"Gondi V, Deshmukh S, Brown PD et al (2023) Sustained preservation of cognition and prevention of Patient-Reported symptoms with hippocampal avoidance during Whole-Brain radiation therapy for brain metastases: final results of NRG oncology CC001. Int J Radiat Oncol Biol Phys 117:571\u2013580. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.04.030","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5035_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.adro.2019.07.012","volume":"5","author":"AB Barbour","year":"2020","unstructured":"Barbour AB, Jacobs CD, Williamson H et al (2020) Radiation therapy practice patterns for brain metastases in the united States in the stereotactic radiosurgery era. Adv Radiat Oncol 5:43\u201352. https:\/\/doi.org\/10.1016\/j.adro.2019.07.012","journal-title":"Adv Radiat Oncol"},{"key":"5035_CR13","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/jjco\/hyad026","volume":"53","author":"Y Koide","year":"2023","unstructured":"Koide Y, Nagai N, Miyauchi R et al (2023) Recent trends of characteristics and treatments in adults with newly diagnosed brain metastases. Jpn J Clin Oncol 53:572\u2013580. https:\/\/doi.org\/10.1093\/jjco\/hyad026","journal-title":"Jpn J Clin Oncol"},{"key":"5035_CR14","first-page":"1","volume":"8","author":"R Singh","year":"2022","unstructured":"Singh R, Didwania P, Lehrer EJ et al (2022) Repeat stereotactic radiosurgery for locally recurrent brain metastases previously treated with stereotactic radiosurgery: A systematic review and meta-analysis of efficacy and safety. J Radiosurg SBRT 8:1\u201310","journal-title":"J Radiosurg SBRT"},{"key":"5035_CR15","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1620\/tjem.223.125","volume":"223","author":"Y Mariya","year":"2011","unstructured":"Mariya Y, Sekizawa G, Matsuoka Y et al (2011) Repeat stereotactic radiosurgery in the management of brain metastases from non-small cell lung cancer. Tohoku J Exp Med 223:125\u2013131. https:\/\/doi.org\/10.1620\/tjem.223.125","journal-title":"Tohoku J Exp Med"},{"key":"5035_CR16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11060-013-1191-6","volume":"115","author":"DH Kim","year":"2013","unstructured":"Kim DH, Schultheiss TE, Radany EH et al (2013) Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery. J Neurooncol 115:37\u201343. https:\/\/doi.org\/10.1007\/s11060-013-1191-6","journal-title":"J Neurooncol"},{"key":"5035_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3171\/2016.6.gks161404","volume":"125","author":"T Koiso","year":"2016","unstructured":"Koiso T, Yamamoto M, Kawabe T et al (2016) Follow-up results of brain metastasis patients undergoing repeat gamma knife radiosurgery. J Neurosurg 125:2\u201310. https:\/\/doi.org\/10.3171\/2016.6.gks161404","journal-title":"J Neurosurg"},{"key":"5035_CR18","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1016\/j.wneu.2018.11.238","volume":"123","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang H, Song Y et al (2019) A second course of stereotactic image-guided robotic radiosurgery for patients with cerebral metastasis. World Neurosurg 123:e621\u2013e628. https:\/\/doi.org\/10.1016\/j.wneu.2018.11.238","journal-title":"World Neurosurg"},{"key":"5035_CR19","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1097\/00006123-200004000-00017","volume":"46","author":"JC Chen","year":"2000","unstructured":"Chen JC, Petrovich Z, Giannotta SL et al (2000) Radiosurgical salvage therapy for patients presenting with recurrence of metastatic disease to the brain. Neurosurgery 46:860\u2013866 discussion 866-7. https:\/\/doi.org\/10.1097\/00006123-200004000-00017","journal-title":"Neurosurgery"},{"key":"5035_CR20","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.ijrobp.2015.04.036","volume":"92","author":"DB Shultz","year":"2015","unstructured":"Shultz DB, Modlin LA, Jayachandran P et al (2015) Repeat courses of stereotactic radiosurgery (SRS), deferring whole-brain irradiation, for new brain metastases after initial SRS. Int J Radiat Oncol Biol Phys 92:993\u2013999. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.04.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5035_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s11060-015-1937-4","volume":"126","author":"G Minniti","year":"2016","unstructured":"Minniti G, Scaringi C, Paolini S et al (2016) Repeated stereotactic radiosurgery for patients with progressive brain metastases. J Neurooncol 126:91\u201397. https:\/\/doi.org\/10.1007\/s11060-015-1937-4","journal-title":"J Neurooncol"},{"key":"5035_CR22","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.wneu.2017.04.103","volume":"104","author":"P Koffer","year":"2017","unstructured":"Koffer P, Chan J, Rava P et al (2017) Repeat stereotactic radiosurgery for locally recurrent brain metastases. World Neurosurg 104:589\u2013593. https:\/\/doi.org\/10.1016\/j.wneu.2017.04.103","journal-title":"World Neurosurg"},{"key":"5035_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3171\/2016.5.JNS153051","volume":"127","author":"WH McKay","year":"2017","unstructured":"McKay WH, McTyre ER, Okoukoni C et al (2017) Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery. J Neurosurg 127:148\u2013156. https:\/\/doi.org\/10.3171\/2016.5.JNS153051","journal-title":"J Neurosurg"},{"key":"5035_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3389\/fonc.2017.00279","volume":"7","author":"N Rana","year":"2017","unstructured":"Rana N, Pendyala P, Cleary RK et al (2017) Long-term outcomes after salvage stereotactic radiosurgery (SRS) following in-field failure of initial SRS for brain metastases. Front Oncol 7:279. https:\/\/doi.org\/10.3389\/fonc.2017.00279","journal-title":"Front Oncol"},{"key":"5035_CR25","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3340\/jkns.2017.0238","volume":"61","author":"I-Y Kim","year":"2018","unstructured":"Kim I-Y, Jung S, Jung T-Y et al (2018) Repeat stereotactic radiosurgery for recurred metastatic brain tumors. J Korean Neurosurg Soc 61:633\u2013639. https:\/\/doi.org\/10.3340\/jkns.2017.0238","journal-title":"J Korean Neurosurg Soc"},{"key":"5035_CR26","doi-asserted-by":"publisher","first-page":"e0198692","DOI":"10.1371\/journal.pone.0198692","volume":"13","author":"P Balermpas","year":"2018","unstructured":"Balermpas P, Stera S, von der M\u00fcller J et al (2018) Repeated in-field radiosurgery for locally recurrent brain metastases: feasibility, results and survival in a heavily treated patient cohort. PLoS ONE 13:e0198692. https:\/\/doi.org\/10.1371\/journal.pone.0198692","journal-title":"PLoS ONE"},{"key":"5035_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/s11060-019-03323-8","volume":"145","author":"C Iorio-Morin","year":"2019","unstructured":"Iorio-Morin C, Mercure-Cyr R, Figueiredo G et al (2019) Repeat stereotactic radiosurgery for the management of locally recurrent brain metastases. J Neurooncol 145:551\u2013559. https:\/\/doi.org\/10.1007\/s11060-019-03323-8","journal-title":"J Neurooncol"},{"key":"5035_CR28","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10585-019-10004-3","volume":"37","author":"L Nicosia","year":"2020","unstructured":"Nicosia L, Figlia V, Mazzola R et al (2020) Repeated stereotactic radiosurgery (SRS) using a non-coplanar mono-isocenter (HyperArc\u2122) technique versus upfront whole-brain radiotherapy (WBRT): a matched-pair analysis. Clin Exp Metastasis 37:77\u201383. https:\/\/doi.org\/10.1007\/s10585-019-10004-3","journal-title":"Clin Exp Metastasis"},{"key":"5035_CR29","doi-asserted-by":"publisher","first-page":"10712","DOI":"10.1038\/s41598-022-13853-3","volume":"12","author":"W-J Lee","year":"2022","unstructured":"Lee W-J, Choi J-W, Kong D-S et al (2022) Clinical outcomes of patients with multiple courses of radiosurgery for brain metastases from non-small cell lung cancer. Sci Rep 12:10712. https:\/\/doi.org\/10.1038\/s41598-022-13853-3","journal-title":"Sci Rep"},{"key":"5035_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1001\/jamaoncol.2021.7008","volume":"8","author":"RO Kowalchuk","year":"2022","unstructured":"Kowalchuk RO, Johnson-Tesch BA, Marion JT et al (2022) Development and assessment of a predictive score for vertebral compression fracture after stereotactic body radiation therapy for spinal metastases. JAMA Oncol 8:412\u2013419. https:\/\/doi.org\/10.1001\/jamaoncol.2021.7008","journal-title":"JAMA Oncol"},{"key":"5035_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3171\/2022.4.JNS212597","volume":"138","author":"PK Sneed","year":"2023","unstructured":"Sneed PK, Chan JW, Ma L et al (2023) Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases. J Neurosurg 138:104\u2013112. https:\/\/doi.org\/10.3171\/2022.4.JNS212597","journal-title":"J Neurosurg"},{"key":"5035_CR32","doi-asserted-by":"publisher","unstructured":"Touati R, Bourbonne V, Dissaux G et al (2023) Re-irradiation by stereotactic radiotherapy of brain metastases in the case of local recurrence. Cancers (Basel) 15. https:\/\/doi.org\/10.3390\/cancers15030996","DOI":"10.3390\/cancers15030996"},{"key":"5035_CR33","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s11060-023-04358-8","volume":"163","author":"N Nagai","year":"2023","unstructured":"Nagai N, Koide Y, Shindo Y et al (2023) Retrospective non-inferiority study of stereotactic radiosurgery for more than ten brain metastases. J Neurooncol 163:385\u2013395. https:\/\/doi.org\/10.1007\/s11060-023-04358-8","journal-title":"J Neurooncol"},{"key":"5035_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1227\/01.NEU.0000333263.31870.31","volume":"63","author":"IM Dequesada","year":"2008","unstructured":"Dequesada IM, Quisling RG, Yachnis A, Friedman WA (2008) Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study. Neurosurgery 63:898\u2013903 discussion 904. https:\/\/doi.org\/10.1227\/01.NEU.0000333263.31870.31","journal-title":"Neurosurgery"},{"key":"5035_CR35","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2217\/fon.13.271","volume":"10","author":"AJ Walker","year":"2014","unstructured":"Walker AJ, Ruzevick J, Malayeri AA et al (2014) Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression? Future Oncol 10:1277\u20131297. https:\/\/doi.org\/10.2217\/fon.13.271","journal-title":"Future Oncol"},{"key":"5035_CR36","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16:e270\u2013e278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"key":"5035_CR37","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ijrobp.2023.07.015","volume":"118","author":"B Vellayappan","year":"2024","unstructured":"Vellayappan B, Lim-Fat MJ, Kotecha R et al (2024) A systematic review informing the management of symptomatic brain radiation necrosis after stereotactic radiosurgery and international stereotactic radiosurgery society recommendations. Int J Radiat Oncol Biol Phys 118:14\u201328. https:\/\/doi.org\/10.1016\/j.ijrobp.2023.07.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5035_CR38","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/jamaoncol.2023.4492","volume":"9","author":"ES Lebow","year":"2023","unstructured":"Lebow ES, Pike LRG, Seidman AD et al (2023) Symptomatic necrosis with Antibody-Drug conjugates and concurrent stereotactic radiotherapy for brain metastases. JAMA Oncol 9:1729\u20131733. https:\/\/doi.org\/10.1001\/jamaoncol.2023.4492","journal-title":"JAMA Oncol"},{"key":"5035_CR39","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11060-024-04681-8","volume":"168","author":"Y Koide","year":"2024","unstructured":"Koide Y, Nagai N, Adachi S et al (2024) Impact of concurrent antibody-drug conjugates and radiotherapy on symptomatic radiation necrosis in breast cancer patients with brain metastases: a multicenter retrospective study. J Neurooncol 168:415\u2013423. https:\/\/doi.org\/10.1007\/s11060-024-04681-8","journal-title":"J Neurooncol"},{"key":"5035_CR40","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41523-024-00711-w","volume":"10","author":"VM Khatri","year":"2024","unstructured":"Khatri VM, Mestres-Villanueva MA, Yarlagadda S et al (2024) Multi-institutional report of trastuzumab Deruxtecan and stereotactic radiosurgery for HER2 positive and HER2-low breast cancer brain metastases. NPJ Breast Cancer 10:100. https:\/\/doi.org\/10.1038\/s41523-024-00711-w","journal-title":"NPJ Breast Cancer"},{"key":"5035_CR41","doi-asserted-by":"publisher","unstructured":"Pike LRG, Miao E, Boe LA et al (2024) Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC). J Clin Oncol JCO 2302668. https:\/\/doi.org\/10.1200\/JCO.23.02668","DOI":"10.1200\/JCO.23.02668"},{"key":"5035_CR42","doi-asserted-by":"publisher","unstructured":"Noguchi M, Shindo Y, Wakabayashi K, Koide Y (2024) Significance of up-front stereotactic radiosurgery for non-small cell lung cancer patients with brain metastases in the era of new generation tyrosine kinase inhibitors. J Clin Oncol JCO 2401876. https:\/\/doi.org\/10.1200\/JCO-24-01876","DOI":"10.1200\/JCO-24-01876"},{"key":"5035_CR43","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s11060-017-2442-8","volume":"133","author":"JM Kim","year":"2017","unstructured":"Kim JM, Miller JA, Kotecha R et al (2017) The risk of radiation necrosis following stereotactic radiosurgery with concurrent systemic therapies. J Neurooncol 133:357\u2013368. https:\/\/doi.org\/10.1007\/s11060-017-2442-8","journal-title":"J Neurooncol"},{"key":"5035_CR44","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/cancers13010070","volume":"13","author":"T Gutschenritter","year":"2020","unstructured":"Gutschenritter T, Venur VA, Combs SE et al (2020) The judicious use of stereotactic radiosurgery and hypofractionated stereotactic radiotherapy in the management of large brain metastases. Cancers (Basel) 13:70. https:\/\/doi.org\/10.3390\/cancers13010070","journal-title":"Cancers (Basel)"},{"key":"5035_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11060-023-04265-y","volume":"162","author":"M Yan","year":"2023","unstructured":"Yan M, Lee M, Myrehaug S et al (2023) Hypofractionated stereotactic radiosurgery (HSRS) as a salvage treatment for brain metastases failing prior stereotactic radiosurgery (SRS). J Neurooncol 162:119\u2013128. https:\/\/doi.org\/10.1007\/s11060-023-04265-y","journal-title":"J Neurooncol"},{"key":"5035_CR46","doi-asserted-by":"publisher","first-page":"397","DOI":"10.18999\/nagjms.81.3.397","volume":"81","author":"Y Koide","year":"2019","unstructured":"Koide Y, Tomita N, Adachi S et al (2019) Retrospective analysis of hypofractionated stereotactic radiotherapy for tumors larger than 2\u00a0cm. Nagoya J Med Sci 81:397\u2013406. https:\/\/doi.org\/10.18999\/nagjms.81.3.397","journal-title":"Nagoya J Med Sci"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05035-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05035-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T13:13:31Z","timestamp":1750857211000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05035-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["5035"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05035-8","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"6 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"YK has a speaker\u2019s bureau for Hitachi Co., received honoraria for presentations in global breast cancer conference, and received research funding from JSPS (Grant Number 23K14669). HT has a speaker\u2019s bureau for Novartis and GE Healthcare Pharma. TK has a speaker\u2019s bureau for Merck biopharma Co. Hitachi Co. MSD Co. Janssen Pharmaceutical Co. AstraZeneka Co, Otsuka Pharmaceutical Fsactory, Inc, Shizuoka Cancer Center, Tohoku University, and Sapporo Medical University, and received honoraria for wiring from Nankodo Co., Ltd, Tokyo Igakusha, Gakken Holdings Co., Ltd., Nagoya University Press, Gan to Kagakuryoho Publishing Co., Gakken Medical Shujunsha Co., Ltd, and Convention Linkage, Inc., and received research funding from Health Science Research Grants for the Grant-in-Aid for Cancer Research from the Ministry of Health, Labour and Welfare of Japan [20\u00a0S-5, 20\u00a0S-6, 17-17, 16-12, 17\u00a0S-5 H21-018, H24-007 to all authors], and National Cancer for Research and Development Funds, Japan [23-A-16, 23-A-21, 26-A-4, and 2020-J-3].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}